MyFinsight
Home
Blog
About
Contact
Download
Download image
Trade accounts
receivable, net
$12,480K
Inventories
$1,129K
Prepaid and other
current assets
$1,097K
Restricted cash and cash
equivalents
$578K
Property and equipment,
gross
$534K
Total current assets
$15,284K
Intangible asset, net (note
7)
$4,348K
Property and equipment,
net
$418K
Operating lease
right-of-use assets
$182K
Other noncurrent
assets
$42K
Less accumulated
depreciation
$116K
Total assets
$20,274K
Accumulated deficit
-$897,390K
Accumulated other
comprehensive loss
-$8,818K
Total liabilities,
convertible and redeemable...
$20,274K
Total stockholders
deficit
-$74,336K
Additional paid-in capital
$831,859K
Common stock, 0.0001
par value...
$13K
Total liabilities
$89,711K
Convertible and redeemable
preferred stock
$4,899K
Total current
liabilities
$84,820K
Contingent liabilities -
noncurrent (note 7)
$4,837K
Operating lease
liabilities - noncurrent
$54K
Convertible notes-Adjuvant
Notes
$32,770K
Convertible notes-Baker
Bros Notes
$20,097K
Accounts payable
$13,153K
Other current
liabilities
$12,016K
Accrued compensation
$2,587K
Convertible notes-Related
Party
$1,352K
Accrued expenses
$1,292K
Derivative liabilities
$1,006K
Contingent liabilities -
current (note 7)
$272K
Short-term debt
$147K
Operating lease
liabilities current
$128K
Back
Back
Balance Sheet
source: myfinsight.com
Evofem Biosciences, Inc. (EVFM)
Evofem Biosciences, Inc. (EVFM)